• Journal of Pharmaceutical Investigation
• /
• 제32권2호
• /
• pp.127-133
• /
• 2002

Levosulpiride is the 1evo-enantiomer form of racemic sulpiride, a benzamide derivative selectively inhibiting dopaminergic $D_2$ receptors at the trigger zone both in the central nervous system and in the gastrointestinal tract. The purpose of the present study was to evaluate the bioequiva1ence of two levosulpiride tablets, Levopride (SK Pharmaceutical Co., Ltd.) and Levopid (Dae Won Pharmaceutical Co., Ltd.), according to the guidelines of Korea Food and Drug Administration (KFDA). The levosulpiride release from the two levosulpiride tablets in vitro was tested using KP VII Apparatus II method with various different kinds of dissolution media (pH 1.2, 4.0, 6.8 buffer solution and water). Twenty eight normal male volunteers, $23.82{\pm}3.26$ years in age and $69.13{\pm}8.58$ kg in body weight, were divided into two groups and a randomized $2{\times}2$ cross-over study was employed. After one tablet containing 25 mg of levosulpiride was orally administered, blood was taken at predetermined time intervals and the concentrations of levosulpiride in serum were determined using HPLC method with fluorescence detector. The dissolution profiles of two levosulpiride tablets were very similar at all dissolution media. Besides, the pharmacokinetic parameters such as $AUC_t,\;C_{max}\;and\;T_{max}$ were calculated and ANOVA test was utilized for the statistical analysis of the parameters using logarithmically transformed $AUC_t\;and\;C_{max}$ and untransformed $T_{max}$. The results showed that the differences in $AUC_t,\;C_{max}\;and\;T_{max}$ between two tablets based on the Levopride were -1.17%, 1.20% and -1.09%, respectively. There were no sequence effects between two tablets in these parameters. The 90% confidence intervals using logarithmically transformed data were within the acceptance range of log(0.8) to log(1.25) $(e.g.,\;log(0.93){\sim}log(1.07)\;and\;log(0.90){\sim}log(1.14)\;for\;AUC_t\;and\;C_{max}$, respectively). The 90% confidence interval using untransformed data was within ${\pm}20%$ $(e.g.,\;-19.47{\sim}16.20\;for\;T_{max})$. All parameters met the criteria of KFDA guideline for bioequivalence, indicating that Levopid tablet is bioequivalent to Levopride tablet.

• 한국미생물·생명공학회지
• /
• 제31권2호
• /
• pp.145-150
• /
• 2003

Acinetobacter sp. SY-01가 생산하는 lipase는 소염진통제로 쓰이는 azolerP 의약품 중간체인 두 enantiomer를 가진 rcemate에 대해 enantioselectivity를 가지는 효소로써 chiral drug를 생산하는데 있어 중요한 역할을 수행한다. Acinetobacter sp. SY-01 lipase 효소의 다량 생산을 위한 여러 가지 최적 조건을 조사하였다. 탄소원으로는 여러 가지 천연 오일을 이용하여 실험한 결과 0.2% olive oil이 가장 좋았으며, 최적 온도와 pH는 30도와 pH 7이였다. EH한 금속이온과 유기용매 안정성에 있어서는 $Fe^{2＋}$ 과 $Ca^{2＋}$ DMSO가 좋은 효과를 나타냇었다. 특히 DMSO는 유기용매가 첨가되지 않았을 때보다 약 2.5배 높은 효소 활성을 나타내었다. 계면활성제 이용에 있어서는 tritom X-100을 이용했을 때 좋은 효과를 나타냈다. Acinetobacter sp. SY-01가 생산하는 lipase 효소의 최적 배지 조성은 0.8% yeast extract, 0.2% olive oil 0.4% triton X-100, 40% DMSO, 0.1 % $NH_4$Cl% 0.4%$K_2HPO_4$ 3.9% $NaH_2PO_4$ 0.03% $CaCl_22H_2O$ 0.01% $FeSO_4$$7H_2O$(pH 7.0)이다.

• 한국미생물·생명공학회지
• /
• 제35권4호
• /
• pp.285-291
• /
• 2007

대장균 BL21(DE3)에 Caulobacter crescentus epoxide hydrolase (CcEH)를 발현시킨 제조합균주를 이용하여 광학수렴 가수분해(enantioconvergent hydrolysis) 반응을 수행하였으며 라세믹 에폭사이드 기질로부터 광학활성 diol을 생합성하는 조건을 최적화하였다. 반응최적화를 위하여, 계면활성제의 첨가와 반응온도가 생성물인 diol의 광학순도 및 수율에 미치는 영향을 분석하였으며 또한 생성물인 diol에 의한 EH의 가수분해활성 저해효과를 측정하였다. 재조합 CcEH를 생촉매로 사용한 광학수렴 반응에서 Tween 80을 2%(w/v)첨가하여 $10^{\circ}C$로 반응시켰을 때 20 mM 라세믹 styrene oxide로부터 광학순도 92%의 (R)-phenyl-1,2-ethanediot을 수율 56%로 얻을 수 있었다. 기질인 라세믹 styrene oxide를 50 mM 농도로 사용한 경우, 광학순도 87% (R)-phenyl-1,2-ethanediol을 77% 얻을 수 있었다. 생성물인 diol의 저해효과를 실험한 경우, 라세믹 phenyl-1,2-ethanediol, (R)-phenyl-1,2-ethanediol 및 (S)-phenyl-1,2-ethanediol은 10 mM 농도에서부터 재조합 CcEH의 가수분해활성을 현저하게 저해하는 것으로 나타났다. 위의 결과들로 볼 때 CcEH를 사용하여 높은 광학순도의 (R)-phenyl-1,2-ethanediol을 생성하기 위해서는 (R)-styrene oxide의 린치를 선택적으로 공격하는 동시에 생성물에 의해 저해를 받지 않는 partner EH를 개발하는 것이 중요할 것이다.

• 약학회지
• /
• 제38권2호
• /
• pp.149-157
• /
• 1994

The role of nitric oxide(NO) as neurotransmitter in non-adrenergic non-cholinergic (NANC) relaxation induced by electrical stimulation has been studied in circular muscle strips of the rabbit gastric fundus. In the presence of atropine and guanethidine, low frequency$(1{\sim}20\;Hz)$ and short trains (5s) of electrical stimulation induced the frequency-dependent relaxations which were not affected by adrenergic and cholinergic blockage, but abolished by tetrodotoxin, a nerve conductance blocker. L-NNA, a stereospecific inhibitor of NO biosynthesis, inhibited the relaxations induced by electrical stimulation but not affected the relaxation to exogenous NO. The effect of L-NNA was prevented by L-arginine, the precursor of the NO biosynthesis, but not by its enantiomer, D-arginine. Exogenous administration of NO$(10{\sim}100\;{\mu}M)$ caused the concentration-dependent relaxation which showed a similarity to those obtained with electrical stimulation. Hemoglobin, a NO scavenger, abolished the NO-induced relaxations and also markedly inhibited those evoked by electrical stimulation. Application of adenosine triphosphate$(1{\sim}10\;{\mu}M)$ induced concentration-independent contractions, but in high dose caused temporary contraction followed by relaxation which was not affected by L-NNA. Exogenous vasoactive intestinal polypeptide$(10{\sim}100\;nM)$ induced the concentration-dependent relaxation, while its effects were slower in onset and more persistent than those induced by short trains and low frequencies of electrical stimulation. Based on above results, it is suggested that NO is the principal neurotransmitter of NANC nerve at relaxation induced by short trains and low frequencies of electrical stimulation in the rabbit gastric fundus.

• The Korean Journal of Physiology
• /
• 제28권1호
• /
• pp.37-50
• /
• 1994

Synthetic potassium channel openers (KCOs) are agents capable of opening K-channels in excitable cells. These agents are known to have their maximal potency in the smooth muscle tissue, especially in the vascular smooth muscle. Much attention has been focused on the type of K-channel that is responsible for mediating the effects of KCOs. As the KCO-induced changes are antagonized by glibenclamide, an $K_{ATP}$ (ATP-sensitive K-channel) blocker in the pancreatic ${\beta}-cell,\;K_{ATP}$ was suggested to be the channel responsible. However, there also are many results in favor of other types of K-channel $$(maxi-K,\;small\;conductance\;K_{Ca,}\; SK_{ATP}) mediating the effects of KCOs. Effects of lemakalim, (-)enantiomer of cromakalim (BRL 34915), on the spontaneous contractions and slow waves, were investigated in the antral circular muscle of the guinea-pig stomach. Membrane currents and the effects on membrane currents and single channel activities were also measured in single smooth muscle cells and excised membrane patches by using the patch clamp method. Lemakalim induced hyperpolarization and inhibited spontaneous contractions in a dose-dependent manner. These effects were blocked by glibenclamide and low concentrations of tetraethyl ammonium (< mM). Glibenclamide blocked the effect of lemakalim on the membrane potential and slow waves. The mechanoinhibitory effect of lemakalim was blocked by pretreatment with glibenclamide. In a whole ceIl patch clamp condition, lemakalim largely increased outward K currents. These outward K currents were blocked by TEA, glibenclamide and a high concentration of intracelIular EGTA (10 mM). Volatage-gated Ca currents were not affected by lemakalim. In inside-out patch clamp experiments, lemakalim increased the opening frequency of the large conductance $Ca^{2+}-activated$ K channels $(BK_{Ca},\;Maxi-K).$ From these results, it is suggested that lemakalim induces hyperpolarization by opening K-channels which are sensitive to internal Ca and such a hyperpolarization leads to the inhibition of the spontaneous contraction.

• 생명과학회지
• /
• 제18권1호
• /
• pp.136-142
• /
• 2008

Rhodotorula glutinis epoxide hydrolase (EH) 유전자를 pPICZ vector에 이중발현 cassette로 재조합하여 발현시킨 재조합균주 Pichia pastoris를 제작하였으며 라세믹 styrene oxide 혼합물로부터 고순도 광학활성 (S)-styrene oxide를 제조하는데 사용하였다. 본 연구에서 사용된 R. glutinis EH 유전자는 전보에서 사용한 pPICZ B/RgEH plasmid DNA를 주형으로 하여 얻었으며 PCR 방법으로 BglII 제한자리를 돌연변이 시키고 AOX1 promoter $(P_{AOX1})$-RgEH 유전자-전사종결서열($TT_{AOX1}$)을 이중으로 가진 이중발현 cassette를 만들어 P. pastoris의 염색체 DNA에 삽입시켰다. 반응온도를 $30^{\circ}C$로 하였을 때, RgEH를 이중발현 cassette로 발현시킨 재조합균주 P. pastoris의 (R)-styrene oxide에 대한 $V_{max}$ 값은 $2.2{\mu}mol\;min^{-1} (mg\;dcw)^{-1}$으로 단일발현 cassette로 발현시킨 P. pastoris의 $0.4{\mu}mol\;min^{-1}(mg\;dcw)^{-1}$에 비하여 6배 향상되었다. 광학순도가 높은 (S)-styrene oxide를 제조하는 최적조건을 찾기 위하여 입체선택적 가수분해 속도 및 수율에 미치는 detergent 및 온도의 효과를 실험하였으며, Tween 20을 0.5% 첨가하고 $10^{\circ}C$로 반응시킨 경우 10분 반응을 통해 99.9% ee 이상의 고순도 (S)-styrene oxide를 43.4% 얻을 수 있었다.

• KSBB Journal
• /
• 제21권3호
• /
• pp.224-229
• /
• 2006

전산모사 프로그램인 FEMLAB을 이용하여 chiral center를 가지고 있는 racemate인 ibuprofen의 R-form과 S-form의 분리 전산모사 결과와 Kromasil KR100-5CHI-TBB 칼럼을 사용하여 HPLC를 통한 실험데이터를 비교 분석하였다. Hexane/t-BME/acetic acid(45:55:1 v/v%)의 이동상의 조건에서 이론단수(number of theoretical plates), 이론단높이(HETP; Height Equivalent to a Theoretical Plate)을 구하여 축방향 확산계수($Deff_i$)를 계산하였다. PIM(Pulsed Input Method)을 사용하여 분석한 결과 ibuprofen의 농도가 증가할수록 Langmuir 등온흡착식을 따르는 비선형 거동을 보였고, 각 농도에서의 체류시간($t_R$)과 phase ratio를 이용하여 비경쟁적 Langmuir 등온흡착식의 매개변수를 추산하였고, 이 매개변수를 이용하여 경쟁적 Langmuir 등온흡착식을 결정하였다. 실험을 통해 얻은 데이터를 FEMLAB 적용하여 등온흡착식의 변화에 따른 용리띠의 변화와 두 성분이 컬럼을 이동하는 동안 두 성분간 분리 과정을 관찰하였다. Ibuprofen의 농도, 유속을 변화시키면서 실험결과와 전산모사결과를 비교한 결과 실험결과와 전산모사결과가 비슷한 경향성을 보였다. 이와 같이 FEMLAB 전산모사 프로그램의 실험적용 가능성을 확인하였고. 실험과 일치하는 전산모사데이터를 얻기 위해서 고정상내의 세공에서의 물질전달을 포함하는 물질수지식의 적용과 비선형 흡착평형식에 대한 좀 더 정확한 식이 요구된다.

• Translational and Clinical Pharmacology
• /
• 제26권4호
• /
• pp.160-165
• /
• 2018

Indobufen ($Ibustrin^{(R)}$), a reversible inhibitor of platelet aggregation, exists in two enantiomeric forms in 1:1 ratio. Here, we characterized the anti-platelet effect of S- and R-indobufen using response surface modeling using $NONMEM^{(R)}$ and predicted the therapeutic doses exerting the maximal efficacy of each enantioselective S- and R-indobufen formulation. S- and R-indobufen were added individually or together to 24 plasma samples from drug-naïve healthy subjects, generating 892 samples containing randomly selected concentrations of the drugs of 0-128 mg/L. Collagen-induced platelet aggregation in platelet-rich plasma was determined using a Chrono-log Lumi-Aggregometer. Inhibitory sigmoid $I_{max}$ model adequately described the anti-platelet effect. The S-form was more potent, whereas the R-form showed less inter-individual variation. No significant interaction was observed between the two enantiomers. The anti-platelet effect of multiple treatments with 200 mg indobufen twice daily doses was predicted in the simulation study, and the effect of S- or R-indobufen alone at various doses was predicted to define optimal dosing regimen for each enantiomer. Simulation study predicted that 200 mg twice daily administration of S-indobufen alone will produce more treatment effect than S-and R-mixture formulation. S-indobufen produced treatment effect at lower concentration than R-indobufen. However, inter-individual variation of the pharmacodynamic response was smaller in R-indobufen. The present study suggests the optimal doses of R-and S-enantioselective indobufen formulations in terms of treatment efficacy for patients with thromboembolic problems. The proposed methodology in this study can be applied to the develop novel enantio-selective drugs more efficiently.